Bank of Montreal Can reduced its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 71.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 90,308 shares of the business services provider's stock after selling 224,635 shares during the quarter. Bank of Montreal Can owned 0.05% of Genpact worth $3,879,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in Genpact by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 16,962,496 shares of the business services provider's stock worth $728,539,000 after purchasing an additional 61,376 shares during the last quarter. Victory Capital Management Inc. grew its position in Genpact by 18.1% during the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock valued at $423,205,000 after buying an additional 1,511,790 shares during the period. Franklin Resources Inc. increased its holdings in Genpact by 1.3% during the fourth quarter. Franklin Resources Inc. now owns 4,203,956 shares of the business services provider's stock worth $180,560,000 after buying an additional 55,771 shares during the last quarter. Geode Capital Management LLC raised its position in Genpact by 3.6% in the fourth quarter. Geode Capital Management LLC now owns 3,825,344 shares of the business services provider's stock worth $170,175,000 after acquiring an additional 133,938 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in Genpact by 8.7% in the fourth quarter. JPMorgan Chase & Co. now owns 3,400,636 shares of the business services provider's stock valued at $146,057,000 after acquiring an additional 271,295 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
Insider Buying and Selling at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 2.80% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts recently commented on the stock. Needham & Company LLC lifted their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and upped their price target for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Mizuho lifted their price objective on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Finally, Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price objective for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. Six research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $48.44.
View Our Latest Research Report on G
Genpact Price Performance
Shares of G traded down $0.91 during midday trading on Monday, hitting $46.69. 954,409 shares of the company traded hands, compared to its average volume of 1,345,755. Genpact Limited has a one year low of $30.38 and a one year high of $56.76. The firm has a market cap of $8.20 billion, a P/E ratio of 16.44, a PEG ratio of 1.84 and a beta of 1.06. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The stock has a 50-day moving average of $50.36 and a 200-day moving average of $46.18.
Genpact (NYSE:G - Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, sell-side analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were paid a $0.17 dividend. This is a positive change from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date was Tuesday, March 11th. Genpact's dividend payout ratio is currently 23.94%.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report